# Relmada Therapeutics, Inc.: Form 8-K, filed Dec 30, 2015

- Company: [Relmada Therapeutics, Inc.](/companies/rlmd.md) (CIK 1553643)
- Form: 8-K
- Filed: 2015-12-30
- Accepted by EDGAR: Dec 30, 2015, 12:42 ET
- Period: 2015-12-30
- Accession: 0001213900-15-009790
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1553643/000121390015009790/f8k123015_relmadathera.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1553643/000121390015009790/

## Items reported

- Item 5.07: Shareholder vote results
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1553643/000121390015009790/f8k123015_relmadathera.htm

Filed Dec 30, 2015.
Source: SEC EDGAR, the filing index for accession 0001213900-15-009790. Last ingested by Listed: Nov 13, 2026, 15:42 ET. No prices; not investment advice.
